Efficacy and safety of COVID‐19 vaccines

Cochrane Emergency and Critical Care … - Cochrane Database …, 1996 - cochranelibrary.com
Background Different forms of vaccines have been developed to prevent the SARS‐CoV‐2
virus and subsequent COVID‐19 disease. Several are in widespread use globally …

Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system …

WF Elkhatib, SS Abdelkareem, WS Khalaf, MI Shahin… - Virology journal, 2022 - Springer
The rise of the highly lethal severe acute respiratory syndrome-2 (SARS-2) as corona virus
2019 (COVID-19) reminded us of the history of other pandemics that happened in the last …

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

K Maeda, M Amano, Y Uemura, K Tsuchiya… - Scientific Reports, 2021 - nature.com
While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing
symptomatic infection, their immune response features remain to be clarified. In the present …

A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2

A Gupta, A Anand, N Jain, S Goswami… - … Therapy-Nucleic Acids, 2021 - cell.com
The recent SARS-CoV-2 outbreak has been declared a global health emergency. It will take
years to vaccinate the whole population to protect them from this deadly virus, hence the …

Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants

M Amano, S Otsu, K Maeda, Y Uemura, Y Shimizu… - Scientific Reports, 2022 - nature.com
In the present prospective study, 225 individuals in Kumamoto General Hospital, Japan, who
received two-doses of BNT162b2 vaccine were enrolled/followed up over 150 days and …

Ethical considerations of the vaccine development process and vaccination: a scoping review

H Jalilian, M Amraei, E Javanshir… - BMC Health Services …, 2023 - Springer
Background Various vaccines have been developed and distributed worldwide to control
and cope with COVID-19 disease. To ensure vaccines benefit the global community, the …

Neutralization against Omicron sublineages (BA. 2/BA. 5/BQ. 1.1/XBB/XBB. 1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT …

M Amano, S Otsu, Y Uemura, Y Ichikawa… - Scientific Reports, 2023 - nature.com
Abstract SARS-CoV-2-BA. 4/5-adapted-bivalent-BNT162b2-vaccine (bvBNT), developed in
response to the recent emergence of immune-evasive Omicron-variants, has been given to …

[PDF][PDF] A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines

RS Singh, A Singh, GD Masih, G Batra, AR Sharma… - Heliyon, 2023 - cell.com
The aim of this study is to comprehensively analyze previous viral vaccine programs and
identify potential challenges and effective measures for the COVID-19 vaccine program …

Real world estimate of vaccination protection in individuals hospitalized for COVID-19

A d'Arminio Monforte, A Tavelli, S De Benedittis, F Bai… - Vaccines, 2022 - mdpi.com
Whether vaccination confers a protective effect against progression after hospital admission
for COVID-19 remains to be elucidated. Observational study including all the patients …

Unveiling associations of COVID-19 vaccine acceptance, hesitancy, and resistance: A cross-sectional community-based adult survey

C Castellano-Tejedor, M Torres-Serrano… - International journal of …, 2021 - mdpi.com
COVID-19 vaccines are essential to limit and eliminate the infectious disease. This research
aims to identify strong vaccination resistance profiles and/or hesitation considering health …